메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Ying Huang (Medical School of Nanjing University) Chenjie Xu (Nanjing Medical University) Tao Zeng (Kunshan Hospital of Integrated Traditional Chinese and Western Medicine) Zhongming Li (Affiliated Hospital of Nantong University) Yanzhi Xia (Fudan University) Gaojian Tao (Medical School of Nanjing University) Tong Zhu (Medical School of Nanjing University) Lijuan Lu (Medical School of Nanjing University) Jing Li (Medical School of Nanjing University) Taiyuan Huang (Medical School of Nanjing University) Hongbo Huai (Medical School of Nanjing University) Benxiang Ning (Medical School of Nanjing University) Chao Ma (Medical School of Nanjing University) Xinxing Wang (China-Japan Friendship Hospital) Yuhua Chang (Bayingolin Mongolian Autonomous Prefecture People’s Hospital) Peng Mao (China-Japan Friendship Hospital) Jian Lin (Medical School of Nanjing University)
저널정보
대한통증학회 The Korean Journal of Pain The Korean Journal of Pain 제34권 제2호
발행연도
2021.1
수록면
210 - 216 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Postherpetic neuralgia (PHN) is the most common complication of acute herpes zoster. The treatment of PHN remains a challenge for clinical pain management. Despite the effectiveness of anticonvulsants, antidepressants, and lidocaine patches in reducing PHN, many patients still face intractable pain disorders. In this randomized controlled study, we evaluated whether hydromorphone through intravenous patient-controlled analgesia (IV PCA) was effective in relieving PHN. Methods: Patients with PHN were randomly divided into two groups, one group received oral pregabalin with IV normal saline, another group received oral pregabalin with additional IV PCA hydromorphone for two weeks. Efficacy was evaluated at 1, 4, and 12 weeks after the end of the treatments. Results: Two hundred and one patients were followed up for 12 weeks. After treatment, numerical rating scale (NRS) score of patients in the hydromorphone group was significantly lower than that of the control group, and the difference of NRS scores between the two groups was statistically significant at 4 and 12 weeks after treatment. The frequency of breakthrough pain in the hydromorphone group was significantly lower than that in the control group 1 and 4 weeks after treatment. After treatment, the quality of sleep in the hydromorphone group was significantly improved compared with the control group. The most common adverse reactions in the hydromorphone group were dizziness and nausea, with no significant respiratory depression. Conclusions: IV PCA hydromorphone combined with oral pregabalin provides superior pain relief in patients with PHN, which is worthy of clinical application and promotion.

목차

등록된 정보가 없습니다.

참고문헌 (16)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0